Finished
Initial Experience With a New Laparoscopic Based Robotically Assisted Surgical System for Cholecystectomy
NCT03380572 · Imperial College London · Updated 21 May 2019
- What is being tested
- Senhance Assisted Cholecystectomy; Laparoscopic Cholecystectomy
- For
- Biliary Colic; Cholecystitis
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 40 people. The full rules are on the registry page.
- Where
- United Kingdom
- When
- Starts or started 10 Feb 2017, ends 1 Jan 2018. Registered 21 Dec 2017.
- Results
- Posted on the registry on 15 May 2019.
In the researchers' words
The Senhance™ surgical robotic system, previously known as Telelap Alf-X (TransEnterix, Morrisville, NC, USA) has recently become available in the UK. It aims to provide the robotic benefits of greater accuracy, dexterity and control with similar operational costs to traditional laparoscopy. Patients randomly received either a standard laparoscopic cholecystectomy or the Senhance assisted cholecystectomy based on scheduled surgery date. A prospectively maintained database of the first 20 patients undergoing cholecystectomy with the Senhance Surgical System was retrospectively interrogated and compared to a concurrently treated group of 20 laparoscopically treated patients during the same timeframe.
Sites
- Imperial College NHS TrustLondon, United Kingdom